Cargando…
Dynein Function and Protein Clearance Changes in Tumor Cells Induced by a Kunitz-Type Molecule, Amblyomin-X
Amblyomin-X is a Kunitz-type recombinant protein identified from the transcriptome of the salivary glands of the tick Amblyomma cajennense and has anti-coagulant and antitumoral activity. The supposed primary target of this molecule is the proteasome system. Herein, we elucidated intracellular event...
Autores principales: | Pacheco, Mario T. F., Berra, Carolina M., Morais, Kátia L. P., Sciani, Juliana M., Branco, Vania G., Bosch, Rosemary V., Chudzinski-Tavassi, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257547/ https://www.ncbi.nlm.nih.gov/pubmed/25479096 http://dx.doi.org/10.1371/journal.pone.0111907 |
Ejemplares similares
-
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
por: Maria, Durvanei A., et al.
Publicado: (2018) -
Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell
por: Morais, Katia L. P., et al.
Publicado: (2016) -
Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells
por: Schmidt, Mariana Costa Braga, et al.
Publicado: (2018) -
Structural and functional properties of the Kunitz-type and C-terminal domains of Amblyomin-X supporting its antitumor activity
por: Morais, K. L. P., et al.
Publicado: (2023) -
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X
por: Pavon, Lorena Favaro, et al.
Publicado: (2019)